A cervical abnormality risk prediction model: Can we use clinical information to predict which patients with ASCUS/LSIL pap tests will develop CIN 2/3 or AIS?

Journal of Lower Genital Tract Disease

Volumn 17, Issue 3, 2013, Pages 242-247

  Charlton, Brittany M ^a   Carwile, Jenny L ^a   Michels, Karin B ^a,b   Feldman, Sarah ^b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Colposcopy; Decision support techniques; Uterine cervical dysplasia; Vaginal smears

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; DEMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MEDICAL INFORMATION SYSTEM; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PAPANICOLAOU TEST; PATIENT REFERRAL; PRECANCER; PREDICTION; RISK ASSESSMENT; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DYSPLASIA;

ADOLESCENT; ADULT; AGED; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; MEDICAL HISTORY TAKING; MIDDLE AGED; PAPANICOLAOU TEST; PREDICTIVE VALUE OF TESTS; PROGNOSIS; YOUNG ADULT;

EID: 84880357781     PISSN: 10892591     EISSN: 15260976     Source Type: Journal    
DOI: 10.1097/LGT.0b013e3182730fec     Document Type: Article

References (21)

1. Borruto F, De Ridder M. HPV and Cervical Cancer Achievements in Prevention and Future Prospects. New York, NY: Springer New York; 2012.
2. Insinga RP, Dasbach EJ, Elbasha EH. Epidemiologic natural history and clinical management of human papillomavirus (HPV) disease: a critical and systematic review of the literature in the development of an HPV dynamic transmission model. BMC Infect Dis 2009;9:119.
3. Melnikow J, Nuovo J, Willan AR, Chan BK, Howell LP. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 1998;92(4 pt 2):727-35.
4. Crane JM. Pregnancy outcome after loop electrosurgical excision procedure: a systematic review. Obstet Gynecol 2003; 102(5 pt 1):1058-62.
5. Flanagan SM, Wilson S, Luesley D, Damery SL, Greenfield SM. Adverse outcomes after colposcopy. BMC Womens Health 2011;11:2.
6. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 2006;367:489-98.
7. Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, et al. Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 2007;357:1579-88.
8. Anderson KM, Wilson PW, Odell PM, Kannel WB. An updated coronary risk profile. A statement for health professionals. Circulation 1991;83:356-62.
9. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, et al. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008;117:743-53.
10. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47.
11. Wang SS, Zuna RE, Wentzensen N, Dunn ST, Sherman ME, Gold MA, et al. Human papillomavirus cofactors by disease progression and human papillomavirus types in the study to understand cervical cancer early endpoints and determinants. Cancer Epidemiol Biomarkers Prev 2009;18:113-20.
12. Austin RM, Onisko A, Druzdzel MJ. The Pittsburgh Cervical Cancer Screening Model: a risk assessment tool. Arch Pathol Lab Med 2010;134:744-50.
13. Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-72; discussion 207-12.
14. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982;143:29-36.
15. Hosmer DW, Hjort NL. Goodness-of-fit processes for logistic regression: simulation results. Stat Med 2002;21: 2723-38.
16. SAS Statistical Software, Release 9.2. Cary, NC: SAS Institue Inc.
17. Harris TG, Kulasingam SL, Kiviat NB, Mao C, Agoff SN, Feng Q, et al. Cigarette smoking, oncogenic human papillomavirus, Ki-67 antigen, and cervical intraepithelial neoplasia. Am J Epidemiol 2004;159:834-42.
18. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol 1993;12:186-92.
19. Castellsague X, Munoz N. Chapter 3: cofactors in human papillomavirus carcinogenesisVrole of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 2003;31:20-8.
20. Scheurer ME, Guillaud M, Tortolero-Luna G, Follen M, Adler-Storthz K. Epidemiologic modeling of cervical dysplasia with molecular and cytopathological markers. Gynecol Oncol 2007;107(1 suppl 1):S163-9.
21. Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology Screening Guidelines for the Prevention and Early Detection of Cervical Cancer. J Lower Gen Tract Dis 2012. Epidemiology